• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前检测人类疟原虫寄生虫抗疟药物耐药性的方法。

Current methods for the detection of antimalarial drug resistance in Plasmodium parasites infecting humans.

机构信息

Roslin Institute, University of Edinburgh, UK.

Department of Veterinary Epidemiology and Public Health, School of Veterinary Medicine, University of Surrey, UK.

出版信息

Acta Trop. 2021 Apr;216:105828. doi: 10.1016/j.actatropica.2021.105828. Epub 2021 Jan 16.

DOI:10.1016/j.actatropica.2021.105828
PMID:33465353
Abstract

Malaria is the world's deadliest parasitic disease. Great progress has been made in the fight against malaria over the past two decades, but this has recently begun to plateau, in part due to the global development of antimalarial drug resistance. The ability to track drug resistance is necessary to achieve progress in treatment, disease surveillance and epidemiology, which has prompted the development of advanced diagnostic methods. These new methods provide unprecedented access to information that can help to guide public health policies. Development of new technologies increases the potential for high throughput and reduced costs of diagnostic tests; improving the accessibility of tools to investigate the forces driving disease dynamics and, ultimately, clinical outcomes for malaria patients and public health. This literature review provides a summary of the methods currently available for the detection of antimalarial drug resistance from the examination of patients' blood samples. While no single method is perfect for every application, many of the newly developed methods give promise for more reliable and efficient characterisation of Plasmodium resistance in a range of settings. By exploiting the strengths of the tools available, we can develop a deeper understanding of the evolutionary and spatiotemporal dynamics of this disease. This will translate into more effective disease control, better-informed policy, and more timely and successful treatment for malaria patients.

摘要

疟疾是全球最致命的寄生虫病。在过去的二十年中,在抗击疟疾方面取得了巨大进展,但最近这一进展开始趋于平稳,部分原因是抗疟药物耐药性在全球范围内的发展。为了在治疗、疾病监测和流行病学方面取得进展,有必要具备跟踪耐药性的能力,这促使了先进诊断方法的发展。这些新方法提供了前所未有的信息获取途径,有助于指导公共卫生政策。新技术的发展增加了高通量和降低诊断测试成本的潜力;提高了研究疾病动态驱动力的工具的可及性,并最终提高了疟疾患者和公共卫生的临床结果。本文综述了目前可从患者血液样本检测中检测抗疟药物耐药性的方法。虽然没有一种方法适用于每种应用,但许多新开发的方法有望在各种环境中更可靠、更有效地描述疟原虫的耐药性。通过利用现有工具的优势,我们可以更深入地了解这种疾病的进化和时空动态。这将转化为更有效的疾病控制、更明智的政策以及对疟疾患者更及时和成功的治疗。

相似文献

1
Current methods for the detection of antimalarial drug resistance in Plasmodium parasites infecting humans.当前检测人类疟原虫寄生虫抗疟药物耐药性的方法。
Acta Trop. 2021 Apr;216:105828. doi: 10.1016/j.actatropica.2021.105828. Epub 2021 Jan 16.
2
Malaria Surveillance - United States, 2016.疟疾监测 - 美国,2016 年。
MMWR Surveill Summ. 2019 May 17;68(5):1-35. doi: 10.15585/mmwr.ss6805a1.
3
Malaria surveillance--United States, 2012.疟疾监测——美国,2012 年。
MMWR Surveill Summ. 2014 Dec 5;63(12):1-22.
4
Malaria Surveillance - United States, 2013.疟疾监测 - 美国,2013 年。
MMWR Surveill Summ. 2016 Mar 4;65(2):1-22. doi: 10.15585/mmwr.ss6502a1.
5
[Resistance to the antimalarial drugs].[对抗疟药物的耐药性]
Rev Esp Quimioter. 2016 Sep;29 Suppl 1:72-5.
6
Evolutionary ARMS Race: Antimalarial Resistance Molecular Surveillance.进化性 ARMS 竞赛:抗疟药物耐药性分子监测。
Trends Parasitol. 2018 Apr;34(4):322-334. doi: 10.1016/j.pt.2018.01.001. Epub 2018 Jan 24.
7
[Biological threats to global malaria elimination I Antimalarial drug resistance].[全球疟疾消除面临的生物威胁 I 抗疟药物耐药性]
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2024 May 23;36(3):233-238. doi: 10.16250/j.32.1374.2024091.
8
Drug targets for resistant malaria: Historic to future perspectives.抗药性疟疾的药物靶点:从历史到未来的展望。
Biomed Pharmacother. 2018 Aug;104:8-27. doi: 10.1016/j.biopha.2018.05.009. Epub 2018 May 11.
9
Recent advances in antimalarial drug development.抗疟药物研发的最新进展。
Med Res Rev. 2007 Jan;27(1):65-107. doi: 10.1002/med.20062.
10
Current therapies and future possibilities for drug development against liver-stage malaria.针对肝期疟疾的当前疗法及药物开发的未来可能性
J Clin Invest. 2016 Jun 1;126(6):2013-20. doi: 10.1172/JCI82981.

引用本文的文献

1
Plasmodium falciparum isolates: ex vivo drug response.恶性疟原虫分离株:体外药物反应
J Antimicrob Chemother. 2025 Jul 1;80(7):1813-1822. doi: 10.1093/jac/dkaf129.
2
Antimalarial Drug Resistance: A Brief History of Its Spread in Indonesia.抗疟药耐药性:在印度尼西亚传播的简要历史。
Drug Des Devel Ther. 2023 Jul 5;17:1995-2010. doi: 10.2147/DDDT.S403672. eCollection 2023.
3
How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review.大规模药物给药(双氢青蒿素-哌喹)如何影响耐药性的分子标志物?系统评价。
Malar J. 2022 Jun 11;21(1):186. doi: 10.1186/s12936-022-04181-y.
4
The Drug Resistance of and in Iran: A Review Article.伊朗[具体药物或微生物名称]的耐药性:一篇综述文章 (原文中“and”前后内容缺失,请补充完整后再准确翻译)
Iran J Parasitol. 2021 Apr-Jun;16(2):173-185. doi: 10.18502/ijpa.v16i2.6265.